Table 2.
Linear regression analysis of INB versus baseline and stimulated LH, FSH, testosterone in the delayed puberty and adult cohorts.
| Boys with CHH | Boys with CDGP | Men with CHH | Eugonadal men | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INB versus | INB versus | ||||||||||||
| r | r 2 | P-value | r | r 2 | P-value | r | r 2 | P-value | r | r 2 | P-value | ||
| Baseline LH (IU/L) | 0.0006 | 0.37 | 0.08 | 0.002 | 0.02 | 0.31 | Baseline LH (IU/L) | 0.007 | 0.31 | 0.007 | -0.0008 | 0.003 | 0.82 |
| 4hr LH (IU/L) (GnRHa) | 0.02 | 0.21 | 0.22 | -0.004 | 0.0005 | 0.88 | 30min LH (IU/L) (GnRH) | 0.04 | 0.03 | 0.44 | -0.07 | 0.19 | 0.05 |
| 24hr LH (IU/L) (GnRHa) | 0.009 | 0.37 | 0.08 | 0.003 | 0.002 | 0.76 | 4hr LH (IU/L) (GnRH) | 0.01 | 0.04 | 0.37 | -0.02 | 0.29 | 0.01 |
| Baseline FSH (IU/L) | -0.005 | 0.08 | 0.05 | 0.003 | 0.15 | 0.30 | Baseline FSH (IU/L) | 0.008 | 0.21 | 0.03 | -0.004 | 0.08 | 0.22 |
| 4hr FSH (IU/L) (GnRHa) | 0.04 | 0.22 | 0.20 | -0.05 | 0.35 | <0.0001 | 30min FSH (IU/L) (GnRH) | 0.008 | 0.02 | 0.55 | -0.02 | 0.17 | 0.07 |
| 24hr FSH (IU/L) (GnRHa) | 0.02 | 0.53 | 0.03 | -0.03 | 0.21 | 0.0007 | 4hr FSH (IU/L) (GnRH) | 0.007 | 0.02 | 0.52 | -0.01 | 0.15 | 0.10 |
| Baseline T (nmol/L) | 0.0007 | 0.01 | 0.78 | 0.009 | 0.10 | 0.02 | Baseline T (nmol/L) | 0.05 | 0.16 | 0.07 | -0.01 | 0.01 | 0.67 |
| 4hr T (nmol/L) (GnRHa) | 0.002 | 0.17 | 0.26 | 0.01 | 0.06 | 0.08 | 30min T (nmol/L) (GnRH) | 0.04 | 0.10 | 0.17 | 0.02 | 0.05 | 0.35 |
| 24hr T (nmol/L) (GnRHa) | 0.002 | 0.07 | 0.50 | 0.03 | 0.09 | 0.03 | 4hr T (nmol/L) (GnRH) | 0.04 | 0.08 | 0.23 | 0.01 | 0.01 | 0.62 |
Statistically significant results are highlighted in bold. The regression coefficient r is presented, as well as r2 and p-value after linear regression. CHH, congenital hypogonadotrophic hypogonadism; CDGP, constitutional delay of growth and puberty; LH, luteinising hormone; FSH, follicle stimulating hormone; T, testosterone; GnRH, gonadotrophin releasing hormone; GnRHa, gonadotrophin releasing hormone agonist.